Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DREAMING study: Efficacy of low-dose amitriptyline and mirtazapine for insomnia disorder
2017-003766-27Phase 3Terminated
- Sponsor
- VU University Medical Centre
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Insomnia comparing Low-dose amitriptyline with Low-dose mirtazapine (2 arms). Primary endpoint: Primary insomnia severity outcome. Started Jun 2018; status: terminated.
02
Drugs
amitriptylinemirtazapine
03
Conditions
Insomnia
Beyond the preview
Go deeper on 2017-003766-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003766-27.